hydroxychloroquine has been researched along with Prostatic Neoplasms in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saleem, A | 1 |
| Dvorzhinski, D | 1 |
| Santanam, U | 1 |
| Mathew, R | 1 |
| Bray, K | 1 |
| Stein, M | 1 |
| White, E | 1 |
| DiPaola, RS | 1 |
1 other study available for hydroxychloroquine and Prostatic Neoplasms
| Article | Year |
|---|---|
Effect of dual inhibition of apoptosis and autophagy in prostate cancer.
Topics: Animals; Apoptosis; Autophagy; Biphenyl Compounds; Cell Line, Tumor; Drug Therapy, Combination; Huma | 2012 |